导管消融作为心房颤动一线治疗方案:进展与思考  

Catheter ablation as a first-line treatment strategy for atrial fibrillation:progress and thinking

作　　者：黄松群 郭志福[1] HUANG Song-qun;GUO Zhi-fu(Department of Cardiovasology,The First Affiliated Hospital of Naval Medical University(Second Military Medical University),Shanghai 200433,China)

机构地区：[1]海军军医大学(第二军医大学)第一附属医院心血管内科,上海200433

出　　处：《海军军医大学学报》2022年第4期349-354,共6页Academic Journal of Naval Medical University

基　　金：上海市卫生健康委员会科研项目面上项目(202140497)。

摘　　要：心房颤动是临床上常见的心律失常,严重危害人类健康,早期有效控制心房颤动发作并减少并发症是其治疗重点。鉴于导管消融是有创治疗手段,既往指南均推荐导管消融作为心房颤动的二线治疗策略。近年来随着导管消融技术的进步和优化,导管消融有望取代抗心律失常药物成为心房颤动的一线治疗方案。本文系统介绍了导管消融作为心房颤动一线治疗方案的探索,并探讨了有望成为心房颤动一线治疗的一些新技术。Atrial fibrillation is a common arrhythmia in clinic and seriously endangers human health.The focus of treatment is to effectively control the onset of atrial fibrillation and reduce complications on the early stage.Since catheter ablation is an invasive treatment,previous guidelines have recommended catheter ablation as a second-line treatment strategy.In recent years,with the progress and optimization of catheter ablation technology,catheter ablation is expected to replace antiarrhythmic drugs as the first-line treatment of atrial fibrillation.This paper systematically introduces the exploration of catheter ablation as the first-line treatment of atrial fibrillation,and discusses some new technologies that are expected to become the first-line treatment of atrial fibrillation.

关 键 词：心房颤动 导管消融 脉冲电场消融 冷冻消融 射频消融 

分 类 号：R541.75[医药卫生—心血管疾病]